Advanced Drug Delivery Reviews

Nasal vaccination: a non-invasive vaccine delivery method that holds great promise for the future
pp. 1-3(3)

The nose and paranasal sinuses physiology and anatomy
pp. 5-19(15)
Author: Jones N.

Nasal vaccines
pp. 21-42(22)
Author: Davis S.S.

Manipulating the immune system: humoral versus cell-mediated immunity
pp. 43-54(12)
Authors: McNeela E.A.; Mills K.H.G.

Nasal vaccination using live bacterial vectors
pp. 55-69(15)
Authors: Mielcarek N.; Alonso S.; Locht C.

Cytokines as adjuvants for the induction of mucosal immunity
pp. 71-79(9)
Authors: Boyaka P.N.; McGhee J.R.

Chitosan as a novel nasal delivery system for vaccines
pp. 81-96(16)
Authors: Illum L.; Jabbal-Gill I.; Hinchcliffe M.; Fisher A.N.; Davis S.S.

Polymeric lamellar substrate particles for intranasal vaccination
pp. 97-111(15)
Authors: Jabbal-Gill I.; Lin W.; Kistner O.; Davis S.S.; Illum L.

Synthetic biomimetic supra molecular Biovector(TM) (SMBV(TM)) particles for nasal vaccine delivery
pp. 113-125(13)
Author: von Hoegen P.

Microparticles for intranasal immunization
pp. 127-141(15)
Authors: Vajdy M.; O'Hagan D.T.

Bacteria-derived particles as adjuvants for non-replicating nasal vaccines
pp. 143-147(5)
Authors: Haneberg B.; Herland Berstad A.K.; Holst J.

Immunostimulating complexes (ISCOMs) for nasal vaccination
pp. 149-159(11)
Authors: Hu K.-F.; Lovgren-Bengtsson K.; Morein B.

Nasal delivery of epitope based vaccines
pp. 161-171(11)
Authors: Olszewska W.; Steward M.W.

Intranasal vaccination against plague, tetanus and diphtheria
pp. 173-201(29)
Authors: Alpar H.O.; Eyles J.E.; Williamson E.D.; Somavarapu S.

Review of intranasal influenza vaccine
pp. 203-211(9)
Author: Glueck R.